Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS

NCT01723683 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Distress Syndrome

Interventions

DRUG: Surfactant

Sponsor

China Medical University Hospital